A002800 Stock Overview
Sinsin Pharmaceutical Co., Ltd manufactures and sells pharmaceutical products in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
Sinsin Pharmaceutical Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩5,410.00 |
| 52 Week High | ₩8,540.00 |
| 52 Week Low | ₩3,860.00 |
| Beta | -0.0027 |
| 1 Month Change | -17.66% |
| 3 Month Change | -11.75% |
| 1 Year Change | 12.24% |
| 3 Year Change | -34.18% |
| 5 Year Change | -31.95% |
| Change since IPO | -32.54% |
Recent News & Updates
Recent updates
Sinsin Pharmaceutical's (KOSDAQ:002800) Profits May Not Reveal Underlying Issues
Mar 20
What Kind Of Shareholders Hold The Majority In Sinsin Pharmaceutical Co., Ltd's (KOSDAQ:002800) Shares?
Mar 06Is Sinsin Pharmaceutical (KOSDAQ:002800) A Risky Investment?
Feb 08
If You Had Bought Sinsin Pharmaceutical (KOSDAQ:002800) Stock A Year Ago, You Could Pocket A 24% Gain Today
Jan 18We're Not Counting On Sinsin Pharmaceutical (KOSDAQ:002800) To Sustain Its Statutory Profitability
Dec 25What Kind Of Investors Own Most Of Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)?
Nov 29Shareholder Returns
| A002800 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -2.5% | 0.5% | -0.4% |
| 1Y | 12.2% | 7.1% | 4.5% |
Return vs Industry: A002800 exceeded the KR Pharmaceuticals industry which returned 7.1% over the past year.
Return vs Market: A002800 exceeded the KR Market which returned 4.5% over the past year.
Price Volatility
| A002800 volatility | |
|---|---|
| A002800 Average Weekly Movement | 5.4% |
| Pharmaceuticals Industry Average Movement | 4.6% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A002800's share price has been volatile over the past 3 months.
Volatility Over Time: A002800's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1959 | 329 | Ki Lee Byoung | www.sinsin.com |
Sinsin Pharmaceutical Co., Ltd manufactures and sells pharmaceutical products in South Korea. It offers various medicinal products, such as plaster, aerosol, topical liquid, emollient, hygiene, and ointment products, as well as adhesive bandages, mosquito repellents, anti-perspirants, cooling sheets, bruise treatment creams, and other products. The company also develops transdermal drug delivery system, and bag on valve inhaler and aerosol solubilzation system.
Sinsin Pharmaceutical Co., Ltd Fundamentals Summary
| A002800 fundamental statistics | |
|---|---|
| Market cap | ₩82.07b |
| Earnings (TTM) | ₩4.68b |
| Revenue (TTM) | ₩102.59b |
17.5x
P/E Ratio0.8x
P/S RatioIs A002800 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A002800 income statement (TTM) | |
|---|---|
| Revenue | ₩102.59b |
| Cost of Revenue | ₩69.27b |
| Gross Profit | ₩33.31b |
| Other Expenses | ₩28.63b |
| Earnings | ₩4.68b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 308.49 |
| Gross Margin | 32.47% |
| Net Profit Margin | 4.56% |
| Debt/Equity Ratio | 71.5% |
How did A002800 perform over the long term?
See historical performance and comparison